|
1
|
Adler B, Schaadt E, Kempkes B,
Zimber-Strobl U, Baier B and Bornkamm GW: Control of Epstein-Barr
virus reactivation by activated CD40 and viral latent membrane
protein 1. Proc Natl Acad Sci USA. 99:437–442. 2002. View Article : Google Scholar
|
|
2
|
Kawai T, Takahashi K, Sato S, Coban C,
Kumar H, Kato H, Ishii KJ, Takeuchi O and Akira S: IPS-1, an
adaptor triggering RIG-I- and Mda5-mediated type I interferon
induction. Nat Immunol. 6:981–988. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brown HJ, Song MJ, Deng H, Wu TT, Cheng G
and Sun R: NF-κB inhibits gammaherpesvirus lytic replication. J
Virol. 77:8532–8540. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kopp E and Ghosh S: Inhibition of NF-kappa
B by sodium salicylate and aspirin. Science. 265:956–959. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yin MJ, Yamamoto Y and Gaynor RB: The
anti-inflammatory agents aspirin and salicylate inhibit the
activity of I (kappa)B kinase-beta. Nature. 396:77–80. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu SF, Wang H, Li ZJ, Deng XY, Xiang H,
Tao YG, Li W, Tang M and Cao Y: Aspirin induces lytic cytotoxicity
in Epstein-Barr virus-positive cells. Eur J Pharmacol. 589:8–13.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu SF, Wang H, Lin XC, Xiang H, Deng XY,
Li W, Tang M and Cao Y: NF-κB inhibitors induce lytic cytotoxicity
in Epstein-Barr virus-positive nasopharyngeal carcinoma. Cell Biol
Int. 32:1006–1013. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Visalli P and van Zeijl M: DNA
encapsidation as a target for anti-herpesvirus drug therapy.
Antiviral Res. 59:73–87. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Meng Q, Hagemeier SR, Fingeroth JD,
Gershburg E, Pagano JS and Kenney SC: The Epstein-Barr virus
(EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase
(EBV-TK), is required for ganciclovir and acyclovir inhibition of
lytic viral production. J Virol. 84:4534–4542. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Harris SA, McGuigan C, Andrei G, Snoeck R,
De Clercq E and Balzarini J: Synthesis and antiviral evaluation of
phosphoramidate derivatives of
(E)-5-(2-bromovinyl)-2′-deoxyuridine. Antivir Chem Chemother.
12:293–300. 2001. View Article : Google Scholar
|
|
11
|
Meyer PR, Rutvisuttinunt W, Matsuura SE,
So AG and Scott WA: Stable complexes formed by HIV-1 reverse
transcriptase at distinct positions on the primer-template
controlled by binding deoxynucleoside triphosphates or foscarnet. J
Mol Biol. 369:41–54. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Burke AP, Yen TS, Shekitka KM and Sobin
LH: Lymphoepithelial carcinoma of the stomach with Epstein-Barr
virus demonstrated by polymerase chain reaction. Mod Pathol.
3:377–380. 1990.PubMed/NCBI
|
|
13
|
Shibata D, Tokunaga M, Uemura Y, Sato E,
Tanaka S and Weiss LM: Association of Epstein-Barr virus with
undifferentiated gastric carcinomas with intense lymphoid
infiltration lymphoepithelioma-like carcinoma. Am J Pathol.
139:469–447. 1991.PubMed/NCBI
|
|
14
|
Takada K: Epstein-Barr virus and gastric
carcinoma. Mol Pathol. 53:255–261. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Israel BF and Kenney SC: Virally targeted
therapies for EBV-associated malignancies. Oncogene. 22:5122–5130.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ji Jung E, Mie Lee Y, Lan Lee B, Soo Chang
M and Ho Kim W: Ganciclovir augments the lytic induction and
apoptosis induced by chemotherapeutic agents in an Epstein-Barr
virus-infected gastric carcinoma cell line. Anticancer Drugs.
18:79–85. 2007.
|
|
17
|
Ryan JL, Fan H, Glaser SL, Schichman SA,
Raab-Traub N and Gulley ML: Epstein-Barr virus quantitation by
real-time PCR and targeting multiple gene segments: A novel
approach to screen for the virus in paraffin-embedded tissue and
plasma. J Mol Diagn. 6:378–385. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hilscher C, Vahrson W and Dittmer DP:
Faster quantitative real-time PCR protocols may lose sensitivity
and show increased variability. Nucleic Acids Res. 33:e1822005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jeong JY, Woo JH, Kim YS, Choi S, Lee SO,
Kil SR, Kim CW, Lee BL, Kim WH, Nam BH and Chang MS: Nuclear
factor-kappa B inhibition reduces markedly cell proliferation in
Epstein-Barr virus-infected stomach cancer, but affects variably in
Epstein-Barr virus-negative stomach cancer. Cancer Invest.
28:113–119. 2010. View Article : Google Scholar
|
|
20
|
Ding L, Li LL, Yang J, Tao YG, Ye M, Shi
Y, Tang M, Yi W, Li XL, Gong JP and Cao Y: Epstein-Barr virus
encoded latent membrane protein 1 modulates nuclear translocation
of telomerase reverse transcriptase protein by activating nuclear
factor-kappaB p65 in human nasopharyngeal carcinoma cells. Int J
Biochem Cell Biol. 37:1881–1889. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pierce JW, Schoenleber R, Jesmok G, Best
J, Moore SA, Collins T and Gerritsen ME: Novel inhibitors of
cytokine-induced IkappaBalpha phosphorylation and endothelial cell
adhesion molecule expression show anti-inflammatory effects in
vivo. J Biol Chem. 272:21096–21103. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sergerie Y and Boivin G: Evaluation of
susceptibility of human herpesvirus 8 to antiviral drugs by
quantitative real-time PCR. J Clin Microbiol. 41:3897–3900. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Westphal EM, Mauser A, Swenson J, Davis
MG, Talarico CL and Kenney SC: Induction of lytic Epstein-Barr
virus (EBV) infection in EBV-associated malignancies using
adenovirus vectors in vitro and in vivo. Cancer Res. 59:1485–1491.
1999.PubMed/NCBI
|
|
24
|
Takimoto T, Iwawaki J, Tanaka S and Umeda
R: Interactions between Epstein-Barr virus (EBV) and human cell
lines: Growth and EBV induction. ORL J Otorhinolaryngol Relat Spec.
52:40–46. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bren GD, Solan NJ, Miyoshi H, Pennington
KN, Pobst LJ and Paya CV: Transcription of the RelB gene is
regulated by NF-kappaB. Oncogene. 20:7722–7733. 2001. View Article : Google Scholar : PubMed/NCBI
|
